AbL Diagnostics SA (ABLD) — Capital Reinvestment Ratio
AbL Diagnostics SA (ABLD) has a Capital Reinvestment Ratio of 0.84x as of June 2025, meaning it reinvests 1% of its operating cash flow (€479.46K) in capital expenditures (€400.39K). Check AbL Diagnostics SA (ABLD) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AbL Diagnostics SA Capital Reinvestment Ratio (2017–2025)
This chart tracks AbL Diagnostics SA's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see AbL Diagnostics SA (ABLD) cash conversion ratio.
Annual Capital Reinvestment Ratio for AbL Diagnostics SA (2017–2025)
Year-by-year Capital Reinvestment Ratio for AbL Diagnostics SA from 2017 to 2025. See AbL Diagnostics SA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | €1.51 Million | €792.67K | ▼ -48.1% |
| 2023 | 1.01x | €926.43K | €938.50K | ▼ -87.3% |
| 2018 | 7.95x | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €675.20K | €305.02K | — |